South San Francisco, CA — September 28, 2018 — Genentech,
New Migraine Prevention Drug Approved By FDA
A new drug used to help prevent migraines in adults
FDA Approves Seysara
Barcelona – 2nd October 2018 — Almirall, S.A. announced today
FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of Nuplazid (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
SAN DIEGO–(BUSINESS WIRE)–Sep. 20, 2018– Acadia Pharmaceuticals Inc. (NASDAQ: ACAD)
FDA takes important steps to encourage appropriate and rational prescribing of opioids through final approval of new safety measures governing the use of immediate-release opioid analgesic medications
September 18, 2018 — Today, the U.S. Food and Drug
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA)
South San Francisco, CA — September 13, 2018 — Genentech,
Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype
THOUSAND OAKS, Calif., Sept. 6, 2018 /PRNewswire/ — Amgen (NASDAQ:
FDA Approves Tiglutik
BERWYN, Pa., Sept. 6, 2018 /PRNewswire/ — ITF Pharma, a
FDA Approves Jivi
WHIPPANY, N.J., Aug. 30, 2018 /PRNewswire/ — Bayer announced today
FDA warns of serious genital infection linked to certain diabetes drugs
Patients are at risk of the infection known as Fournier’s